Reni Benjamin
Stock Analyst at JMP Securities
(2.40)
# 1,418
Out of 4,412 analysts
111
Total ratings
42.5%
Success rate
-1.44%
Average return
Main Sectors:
Top Industries:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines | Reiterates: Market Outperform | $114 | $90.73 | +25.65% | 9 | Apr 10, 2024 | |
| STRO Sutro Biopharma | Reiterates: Market Outperform | $17 | $3.42 | +397.08% | 7 | Apr 3, 2024 | |
| HOWL Werewolf Therapeutics | Initiates: Market Outperform | $12 | $6.21 | +93.24% | 1 | Apr 3, 2024 | |
| BCAB BioAtla | Reiterates: Market Outperform | $12 | $2.25 | +433.33% | 6 | Mar 28, 2024 | |
| PRLD Prelude Therapeutics | Initiates: Market Outperform | $7 | $4.04 | +73.27% | 1 | Mar 13, 2024 | |
| SANA Sana Biotechnology | Maintains: Market Outperform | $8 → $15 | $8.50 | +76.47% | 3 | Mar 1, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Market Outperform | $18 → $25 | $11.54 | +116.64% | 8 | Feb 20, 2024 | |
| INCY Incyte | Downgrades: Market Perform | n/a | $51.18 | - | 14 | Feb 14, 2024 | |
| KURA Kura Oncology | Maintains: Market Outperform | $22 → $32 | $19.00 | +68.42% | 3 | Jan 31, 2024 | |
| INBX Inhibrx | Downgrades: Market Perform | n/a | $34.09 | - | 6 | Jan 23, 2024 | |
| ALLO Allogene Therapeutics | Downgrades: Market Perform | n/a | $2.86 | - | 6 | Jan 5, 2024 | |
| BCYC Bicycle Therapeutics | Maintains: Market Outperform | $44 → $32 | $22.52 | +42.10% | 10 | Dec 20, 2023 | |
| LVTX LAVA Therapeutics | Reiterates: Market Outperform | $6 | $2.64 | +127.27% | 4 | Aug 23, 2023 | |
| ACET Adicet Bio | Downgrades: Market Perform | n/a | $1.81 | - | 3 | Jun 27, 2023 | |
| DCPH Deciphera Pharmaceuticals | Reiterates: Market Outperform | $23 | $14.18 | +62.20% | 5 | Jun 5, 2023 | |
| CUE Cue Biopharma | Reiterates: Outperform | $15 | $1.41 | +963.83% | 2 | May 15, 2023 | |
| EFTR eFFECTOR Therapeutics | Maintains: Market Outperform | $50 → $25 | $1.81 | +1,281.22% | 5 | Jan 9, 2023 | |
| CGEN Compugen | Maintains: Market Outperform | $8 → $4 | $1.90 | +110.53% | 1 | Aug 8, 2022 | |
| MGNX MacroGenics | Upgrades: Market Perform | n/a | $14.37 | - | 2 | Feb 7, 2019 | |
| RGNX REGENXBIO | Upgrades: Strong Buy | n/a | $16.06 | - | 2 | Feb 5, 2019 | |
| LPTX Leap Therapeutics | Maintains: Outperform | n/a | $3.17 | - | 2 | Dec 19, 2018 | |
| VYGR Voyager Therapeutics | Upgrades: Strong Buy | n/a | $7.42 | - | 2 | Nov 15, 2018 | |
| ADVM Adverum Biotechnologies | Downgrades: Market Perform | n/a | $9.39 | - | 2 | Nov 2, 2018 | |
| ADAP Adaptimmune Therapeutics | Maintains: Outperform | n/a | $1.06 | - | 1 | Oct 22, 2018 | |
| ADMA ADMA Biologics | Maintains: Outperform | n/a | $6.44 | - | 2 | Oct 12, 2018 | |
| TGTX TG Therapeutics | Downgrades: Outperform | n/a | $13.91 | - | 1 | Sep 25, 2018 | |
| URGN UroGen Pharma | Downgrades: Market Perform | n/a | $13.82 | - | 1 | Nov 15, 2017 | |
| ONVO Organovo Holdings | Downgrades: Market Perform | n/a | $0.99 | - | 1 | Nov 10, 2017 | |
| BOLD Boundless Bio | Initiates: Market Perform | n/a | $12.07 | - | 1 | Oct 12, 2017 |
Blueprint Medicines
Apr 10, 2024
Reiterates: Market Outperform
Price Target: $114
Current: $90.73
Upside: +25.65%
Sutro Biopharma
Apr 3, 2024
Reiterates: Market Outperform
Price Target: $17
Current: $3.42
Upside: +397.08%
Werewolf Therapeutics
Apr 3, 2024
Initiates: Market Outperform
Price Target: $12
Current: $6.21
Upside: +93.24%
BioAtla
Mar 28, 2024
Reiterates: Market Outperform
Price Target: $12
Current: $2.25
Upside: +433.33%
Prelude Therapeutics
Mar 13, 2024
Initiates: Market Outperform
Price Target: $7
Current: $4.04
Upside: +73.27%
Sana Biotechnology
Mar 1, 2024
Maintains: Market Outperform
Price Target: $8 → $15
Current: $8.50
Upside: +76.47%
Iovance Biotherapeutics
Feb 20, 2024
Maintains: Market Outperform
Price Target: $18 → $25
Current: $11.54
Upside: +116.64%
Incyte
Feb 14, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $51.18
Upside: -
Kura Oncology
Jan 31, 2024
Maintains: Market Outperform
Price Target: $22 → $32
Current: $19.00
Upside: +68.42%
Inhibrx
Jan 23, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $34.09
Upside: -
Allogene Therapeutics
Jan 5, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $2.86
Upside: -
Bicycle Therapeutics
Dec 20, 2023
Maintains: Market Outperform
Price Target: $44 → $32
Current: $22.52
Upside: +42.10%
LAVA Therapeutics
Aug 23, 2023
Reiterates: Market Outperform
Price Target: $6
Current: $2.64
Upside: +127.27%
Adicet Bio
Jun 27, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.81
Upside: -
Deciphera Pharmaceuticals
Jun 5, 2023
Reiterates: Market Outperform
Price Target: $23
Current: $14.18
Upside: +62.20%
Cue Biopharma
May 15, 2023
Reiterates: Outperform
Price Target: $15
Current: $1.41
Upside: +963.83%
eFFECTOR Therapeutics
Jan 9, 2023
Maintains: Market Outperform
Price Target: $50 → $25
Current: $1.81
Upside: +1,281.22%
Compugen
Aug 8, 2022
Maintains: Market Outperform
Price Target: $8 → $4
Current: $1.90
Upside: +110.53%
MacroGenics
Feb 7, 2019
Upgrades: Market Perform
Price Target: n/a
Current: $14.37
Upside: -
REGENXBIO
Feb 5, 2019
Upgrades: Strong Buy
Price Target: n/a
Current: $16.06
Upside: -
Leap Therapeutics
Dec 19, 2018
Maintains: Outperform
Price Target: n/a
Current: $3.17
Upside: -
Voyager Therapeutics
Nov 15, 2018
Upgrades: Strong Buy
Price Target: n/a
Current: $7.42
Upside: -
Adverum Biotechnologies
Nov 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $9.39
Upside: -
Adaptimmune Therapeutics
Oct 22, 2018
Maintains: Outperform
Price Target: n/a
Current: $1.06
Upside: -
ADMA Biologics
Oct 12, 2018
Maintains: Outperform
Price Target: n/a
Current: $6.44
Upside: -
TG Therapeutics
Sep 25, 2018
Downgrades: Outperform
Price Target: n/a
Current: $13.91
Upside: -
UroGen Pharma
Nov 15, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $13.82
Upside: -
Organovo Holdings
Nov 10, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $0.99
Upside: -
Boundless Bio
Oct 12, 2017
Initiates: Market Perform
Price Target: n/a
Current: $12.07
Upside: -